Jaroslaw Zalewski Selected Research

Jaroslaw Zalewski Research Topics

Disease

14	ST Elevation Myocardial Infarction 01/2021 - 11/2005
10	Myocardial Infarction 01/2021 - 09/2004
7	Infarction (Infarctions) 01/2021 - 03/2007
5	Thrombosis (Thrombus) 01/2019 - 02/2010
4	Coronary Artery Disease (Coronary Atherosclerosis) 04/2014 - 07/2011
3	Ischemia 01/2021 - 03/2015
3	Chest Pain (Chest Pains) 06/2015 - 11/2005
2	MINOCA 01/2022 - 01/2019
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Stroke (Strokes) 01/2021 - 01/2018
2	Heart Failure 01/2021 - 05/2012
2	Venous Thromboembolism 06/2020 - 01/2019
2	Hemorrhage 01/2019 - 05/2010
2	Type 2 Diabetes Mellitus (MODY) 05/2015 - 02/2013
2	Ventricular Remodeling 05/2012 - 03/2007
2	Shock 10/2010 - 03/2010
1	Diabetes Mellitus 06/2019
1	Peripheral Arterial Disease 06/2019
1	Thrombophilia 01/2019
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2019
1	Coronary Occlusion 03/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2015
1	Stable Angina 04/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2014
1	Vascular System Injuries 05/2010
1	Pain (Aches) 05/2010
1	Acute Coronary Syndrome 05/2010
1	No-Reflow Phenomenon 10/2007
1	Hypertension (High Blood Pressure) 08/2007
1	Atherosclerosis 08/2007
1	Anterior Wall Myocardial Infarction 03/2007
1	Reperfusion Injury 08/2006
1	Cardiogenic Shock 11/2005
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 09/2004

Drug/Important Bio-Agent (IBA)

7	FibrinIBA 06/2015 - 10/2007
4	Thrombin FDA Link 06/2020 - 05/2010
4	Abciximab (ReoPro)FDA Link 10/2010 - 11/2005
3	Clopidogrel (Plavix)FDA Link 08/2019 - 10/2010
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 04/2014 - 07/2011
2	Troponin T (Troponin T1)IBA 01/2022 - 01/2018
2	Heparin (Liquaemin)FDA LinkGeneric 05/2011 - 11/2005
2	N(2)-(3-trifluoromethylphenyl)guanineIBA 02/2011 - 10/2007
2	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2010 - 11/2005
2	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 10/2007 - 09/2004
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2021
1	ArginaseIBA 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	CitrullineIBA 01/2021
1	OrnithineIBA 01/2021
1	Proline (L-Proline)FDA Link 01/2021
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2021
1	RivaroxabanIBA 06/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2019
1	EnzymesIBA 06/2019
1	N(4)-oleylcytosine arabinosideIBA 01/2019
1	Protein SIBA 01/2019
1	Lipoprotein(a)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Vitamin K FDA Link 01/2019
1	AnticoagulantsIBA 01/2019
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019
1	HomocysteineIBA 01/2019
1	Factor VIII (Coagulation Factor VIII)IBA 01/2019
1	factor V LeidenIBA 01/2019
1	AntithrombinsIBA 01/2019
1	Protein CIBA 01/2019
1	Prothrombin (Factor II)IBA 01/2019
1	lipoprotein A-IIBA 06/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	Blood Glucose (Blood Sugar)IBA 05/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2015
1	Mitochondrial Permeability Transition PoreIBA 03/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2014
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 04/2014
1	oxidized low density lipoproteinIBA 04/2014
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 04/2014
1	AdipokinesIBA 08/2013
1	LeptinIBA 08/2013
1	AdiponectinIBA 08/2013
1	Fibrinolysin FDA Link 03/2012
1	Tenecteplase FDA Link 05/2011
1	Simvastatin (Zocor)FDA LinkGeneric 05/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2010
1	C-Reactive ProteinIBA 08/2007
1	CreatinineIBA 08/2007
1	Indicators and Reagents (Reagents)IBA 08/2007
1	pro-brain natriuretic peptide (1-76)IBA 08/2006
1	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2006
1	DEET (DET)IBA 09/2004

Therapy/Procedure

8	Percutaneous Coronary Intervention 04/2014 - 03/2007
2	Patient Readmission 01/2021 - 01/2018
2	Therapeutics 05/2012 - 11/2005
2	Stents 03/2012 - 02/2010
1	Thrombectomy 08/2019
1	Intravenous Infusions 03/2015
1	Time-to-Treatment 03/2008